Metabolic syndrome and its components as predictors of ischemic stroke in type 2 diabetic patients

被引:19
|
作者
Protopsaltis, Ioannis
Korantzopoulos, Panagiotis [3 ]
Milionis, Haralampos J. [1 ]
Koutsovasilis, Anastasios
Nikolopoulos, Georgios K. [2 ]
Dimou, Eftihia
Kokkoris, Stelios
Brestas, Paris
Elisaf, Moses S. [1 ]
Melidonis, Andreas
机构
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Hellen Ctr Dis Control & Prevent, Athens, Greece
[3] Univ Ioannina, Sch Med, Dept Cardiol, GR-45110 Ioannina, Greece
关键词
ischemic stroke; metabolic syndrome; risk factors; type; 2; diabetes;
D O I
10.1161/STROKEAHA.107.498311
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - The available data regarding the association between metabolic syndrome (MS) or MS components and ischemic stroke in type 2 diabetics are limited and inconsistent. This study aimed to investigate these associations. Methods - Five hundred ninety-nine consecutive type 2 diabetic patients (mean age 60.4 +/- 9.6 years, 54% men) were followed-up for 10.1 years (median period). Baseline clinical and laboratory characteristics and the occurrence of a first-ever ischemic stroke during follow-up were recorded. Results - Seventy-eight patients developed a first-ever ischemic stroke. According to Cox proportional hazard model, waist circumference (hazard ratio, HR: 1.006, 95% CI: 1.002 to 1.010, P = 0.003) and age (HR: 1.061, 95% CI: 1.002 to 1.125, P = 0.04) were significant predictors. After incorporating various combinations of MS components in multivariate models, only age and waist circumference remained significant. Conclusions - MS per se at baseline or combinations of its components do not predict the development of ischemic stroke in type 2 diabetic patients. Waist circumference represents an independent prognostic factor and could be used as a clinical tool for stroke prevention in this population.
引用
收藏
页码:1036 / 1038
页数:3
相关论文
共 50 条
  • [1] Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients
    Protopsaltis, Ioannis
    Nikolopoulos, Georgios
    Dimou, Eftihia
    Brestas, Paris
    Kokkoris, Stelios
    Korantzopoulos, Panagiotis
    Melidonis, Andreas
    ATHEROSCLEROSIS, 2007, 195 (01) : 189 - 194
  • [2] Serum Apelin Level in Type 2 Diabetic Mellitus Patients and Its Association With Metabolic Syndrome Components
    Saadi, Hayder Abdulameer Hammood
    Safarzad, Mahdieh
    Poursharifi, Nahid
    Tatari, Mahin
    Marjani, Abdoljalal
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2023, 13 (02) : 81 - 87
  • [3] Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community
    Ley, Sylvia H.
    Harris, Stewart B.
    Mamakeesick, Mary
    Noon, Tina
    Fiddler, Edith
    Gittelsohn, Joel
    Wolever, Thomas M. S.
    Connelly, Philip W.
    Hegele, Robert A.
    Zinman, Bernard
    Hanley, Anthony J. G.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (06) : 617 - 624
  • [4] Plasma Fibrinogen in Type 2 Diabetic Patients with Metabolic Syndrome and its Relation with Ischemic Heart Disease (IHD) and Retinopathy
    Mahendra, J. V.
    Kumar, Satish D.
    Anuradha, T. S.
    Talikoti, Prashanth
    Nagaraj, R. S.
    Vishali, V.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (01) : BC18 - BC21
  • [5] Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome
    Callahan, Alfred
    Amarenco, Pierre
    Goldstein, Larry B.
    Sillesen, Henrik
    Messig, Mike
    Samsa, Gregory P.
    Altafullah, Irfan
    Ledbetter, Lucy Y.
    MacLeod, Mary J.
    Scott, Russell
    Hennerici, Michael
    Zivin, Justin A.
    Welch, K. Michael A.
    ARCHIVES OF NEUROLOGY, 2011, 68 (10) : 1245 - 1251
  • [6] Impact of the metabolic syndrome and its components combinations on arterial stiffness in Type 2 diabetic men
    Levisianou, D.
    Melidonis, A.
    Adamopoulou, E.
    Skopelitis, E.
    Koutsovasilis, A.
    Protopsaltis, I.
    Zairis, M.
    Kougialis, S.
    Skoularigis, I.
    Koukoulis, G.
    Foussas, S.
    Triposkiadis, F.
    INTERNATIONAL ANGIOLOGY, 2009, 28 (06) : 490 - 495
  • [7] METABOLIC SYNDROME IN PATIENTS WITH ACUTE ISCHEMIC STROKE
    Baloch, Musarat Jehan
    Rajar, Ihsanullah
    Devrajani, Tarachand
    Memon, Hamid Nawaz Ali
    Raza, Samar
    Shah, Syed Zulfiquar Ali
    Khetran, Muhammad Jan
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (04): : 8672 - 8675
  • [8] Metabolic Syndrome in Polish Ischemic Stroke Patients
    Brola, Waldemar
    Sobolewski, Piotr
    Fudala, Malgorzata
    Goral, Anna
    Kasprzyk, Marta
    Szczuchniak, Wiktor
    Pejas-Dulewicz, Renata
    Przybylski, Wojciech
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (09): : 2167 - 2172
  • [9] Metabolic syndrome and menopause in type 2 diabetic patients
    Zeryouh, N.
    Laalaoua, Y.
    Hamdane, C.
    Benyakhlef, S.
    Derbel, S.
    Rouf, S.
    Latrech, H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [10] Hyperleptinemia and metabolic syndrome in type 2 diabetic patients
    Kim, SK
    Kim, HJ
    Hur, KY
    Ahn, CW
    Park, SW
    Cha, BS
    Cho, YW
    Lim, SK
    Kim, KR
    Lee, HC
    DIABETES, 2004, 53 : A349 - A349